G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2006
12/28/2006	WO2006012222A3 Methods of treating smooth muscle cell disorders
12/28/2006	WO2006009702A3 Liver disease-related methods and systems
12/28/2006	WO2006004936A3 Analysis of intracellular modifications
12/28/2006	WO2006003518A3 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract
12/28/2006	WO2005098433A3 Diagnostic assays for alzheimer’s disease
12/28/2006	WO2005089409A3 Sensor constructs and detection methods
12/28/2006	WO2005054295A3 Therapeutic and diagnostic anti-hsp 70 antibodies
12/28/2006	WO2005042701A3 Methods to identify compounds useful for tumor sensitization to dna damage
12/28/2006	WO2005036133A3 Electrode-based detection of polynucleotides
12/28/2006	WO2005024384A3 Devices and methods for separating phospholipids from biological samples
12/28/2006	WO2005012856A3 Devices and methods for determining and predicting breakthrough times and steady state permeation rates of organics
12/28/2006	WO2004041067A3 Prevention and treatment of synucleinopathic disease
12/28/2006	WO2004038372A3 Cdkl1 as modifier of branching morphogenesis and methods of use
12/28/2006	US20060294614 Orphan receptors; drug screening; host cells
12/28/2006	US20060294612 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid
12/28/2006	US20060294607 Human podocalyxin alternative-spliced forms and uses thereof
12/28/2006	US20060294605 Novel human dickkopf-related protein and nucleic acid molecules and uses therefor
12/28/2006	US20060294604 Model for studying the role of genes in tumor resistance to chemotherapy
12/28/2006	US20060294602 Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases
12/28/2006	US20060294601 Compositions, organisms and methodologies employing a novel human kinase
12/28/2006	US20060294600 Modulation of osteoblast activity by fhl2
12/28/2006	US20060293551 Method for producing soil, soil-processing unit, method for processing and unit for processing
12/28/2006	US20060293256 Remedy or preventive for kidney disease and method of diagnosing kidney disease
12/28/2006	US20060293245 P21 derived peptides and uses thereof
12/28/2006	US20060293239 Treatment and Diagnosis of Insulin-Resistant States
12/28/2006	US20060293234 Interaction between MUC1 and beta -catenin can be interrupted using polypeptides or antibodies that specifically bind to the binding site on MUC1, whereby interruption provides the beneficial effect of inhibiting, reducing, and/or retarding invasiveness and metastasis
12/28/2006	US20060293229 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
12/28/2006	US20060292708 Circuit arrangement, redox recycling sensor, sensor assembly and a method for processing a current signal provided by a sensor electrode
12/28/2006	US20060292703 Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
12/28/2006	US20060292702 Method for modeling an simulating a biological system, and model carrying out this method
12/28/2006	US20060292701 Photocrosslinked hydrogel blend surface coatings
12/28/2006	US20060292700 Diffused interrupted lateral flow immunoassay device and method
12/28/2006	US20060292699 Detection of adulterated samples
12/28/2006	US20060292698 Spectroscopic methods for detecting and identifying chelates
12/28/2006	US20060292697 Method to assess organoclay exfoliation and orientation in organoclay/polymer composites
12/28/2006	US20060292696 High speed chromatographic method for hemoglobin variants screening and quantification of hemoglobins a2 and f
12/28/2006	US20060292662 Galleria mellonella derived composition for detecting peptidoglycan, a method for use thereof, and a diagnostic kit containing the same
12/28/2006	US20060292658 Fluorescent compound
12/28/2006	US20060292651 Protein labelling with oº-alkylguanine-dna alkyltrnsferase
12/28/2006	US20060292649 Methods and apparatus for reference lab diagnostics
12/28/2006	US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases
12/28/2006	US20060292647 Reflex supplemental testing - A rapid, efficient and highly accurate method to identify subjects with an infection, disease or other condition
12/28/2006	US20060292646 Methods, biosensors, and kits for detecting and identifying fungi
12/28/2006	US20060292645 Method and reagent for measuring kinase activity
12/28/2006	US20060292644 Novel tumor-associated marker
12/28/2006	US20060292643 Recognition molecules for the treatment and detection of tumours
12/28/2006	US20060292642 Immunoassay of phosphorylated proteins
12/28/2006	US20060292641 Immunoassay method
12/28/2006	US20060292640 identifying markers indicative of the risk of developing a neurodevelopmental disorder caused in part by antibody- or autoantibody-mediated damage of neural tissue
12/28/2006	US20060292639 Splice variant of the vanilloid receptor VR1A
12/28/2006	US20060292638 Sequence #115 as a target for identifying weight modulating compounds
12/28/2006	US20060292637 Biomimetic systems consisting of lipid membranes bound to an electrically conducting substrate
12/28/2006	US20060292636 Quantum (TM) phytase; high sensitivity and specificity for the phytase and are useful in immunoassay methods; capable of detecting low concentrations of phytase
12/28/2006	US20060292635 Stably preserved microspheres
12/28/2006	US20060292633 Method for modulating process mediated by farnesoid activated receptors
12/28/2006	US20060292632 Method for ascertaining the orientation of molecules in biological specimens
12/28/2006	US20060292631 Elastin peptide fingerprints and analysis methods for mmp12 related to copd
12/28/2006	US20060292630 Biosensor and method of analyte measuring
12/28/2006	US20060292629 Chimeric polypeptides and their use
12/28/2006	US20060292627 PB39, a gene dysregulated in prostate cancer, and uses thereof
12/28/2006	US20060292625 Novel human leucine-rich repeat domain containing protein HLLRCR-1
12/28/2006	US20060292623 Signature genes in chronic myelogenous leukemia
12/28/2006	US20060292621 Randomized libraries of zinc finger proteins
12/28/2006	US20060292618 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
12/28/2006	US20060292613 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
12/28/2006	US20060292612 Method for the quality control of functionalized surfaces
12/28/2006	US20060292607 Analysis of tissue samples surrounding malignancies
12/28/2006	US20060292598 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy
12/28/2006	US20060292596 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
12/28/2006	US20060292594 Histone deacetylase (HDAC) inhibitors; drug screening; for determining suitability of glucocorticoid compound or retinoid treatment
12/28/2006	US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
12/28/2006	US20060292591 Genes from the 20q13 amplicon and their uses
12/28/2006	US20060292588 Assay systems, kits and methods for detecting microorganisms
12/28/2006	US20060292587 Polynucleotides encoding insect voltage-gated chloride channel and uses thereof
12/28/2006	US20060292581 Biosensor for small molecule analytes
12/28/2006	US20060292580 Cleavage of nucleic acids
12/28/2006	US20060292579 Methods of enzymatic discrimination enhancement and surface bound double-stranded DNA
12/28/2006	US20060292573 Human orthologues of WART
12/28/2006	US20060292571 Quantification schemes for quantifying nucleic acids
12/28/2006	US20060292570 Novel synthetic binding pairs and uses thereof
12/28/2006	US20060292569 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds
12/28/2006	US20060292565 Methods of cardiovascular disease assessment in an individual
12/28/2006	US20060292563 Methods of diagnosing & treating diabetes and insulin resistance
12/28/2006	US20060292562 Methods of identifying genomic and proteomic biomarkers for cystic fibrosis, arrays comprising the biomarkers and methods of using the arrays
12/28/2006	US20060292561 Dna enzymes
12/28/2006	US20060292558 Methods and apparatus for protein assay diagnostics
12/28/2006	US20060292552 Method for the detection and multiplex quantification of analytes in a sample, using microspheres
12/28/2006	US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception
12/28/2006	US20060292547 diagnosing alcoholism disease in a human by examining molecular alterations in membrane phospholipid and high-energy phosphate metabolism in a human brain with multinuclear magnetic resonance imaging process
12/28/2006	US20060292546 Herg channel-expressing cell
12/28/2006	US20060292545 Moleculary imprinted polymers for extraction of components from foodstruffs
12/28/2006	US20060292246 Characteristic mass spectral fingerprint setting method and rapid identification method for Chinese herbal medicines and prescriptions
12/28/2006	US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide
12/28/2006	US20060292174 Self-assembling nanoparticle drug delivery system
12/28/2006	US20060292173 Multibacterial vaccines and uses thereof
12/28/2006	US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections
12/28/2006	US20060292159 Methods for the inhibition of neovascularization and cancer metastasis
12/28/2006	US20060292156 Recombinant lymphocyte expressing Fc receptor for use in targeting and destroying viral infection and tumor tissues
12/28/2006	US20060292155 Diagnostics and therapeutics for diseases associated with mosaic serine protease (msp)
12/28/2006	US20060292154 A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same

1 ... 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 ... 3937